Stromal collagen IV expression and risk of breast cancer death in ductal carcinoma in situ
{{output}}
Background: Current treatment for ductal carcinoma in situ (DCIS) of the breast is generic, due to lack of risk stratification tools. We investigate the correlation between expression of collagen IV in the breast and risk of dyin... ...
